UNCLASSIFIED

Title:

Oregon High Intensity Drug Trafficking Area Drug Market Analysis

Publication Date: June 2007

Document ID: 2007-R0813-026

This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been vetted with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.

Your questions, comments, and suggestions for future subjects are welcome at any time.  Addresses are provided at the end of the page.

Contents

Preface

Strategic Drug Threat Developments

HIDTA Overview

Drug Threat Overview

Drug Trafficking Organizations

Production

Drug-Related Crime

Illicit Finance

Major Drug Markets
     Portland
     Roseburg/Bend/Pendleton

Outlook

Sources

List of Figures

Figure 1. Oregon High Intensity Drug Trafficking Area and transportation infrastructure.

List of Tables

Table 1. Number of Cannabis Plants Seized From Indoor and Outdoor Grow Sites, Oregon HIDTA region, 2004-2006
Table 2. Methamphetamine Laboratory Seizures in Clackamas, Multnomah, and Washington Counties, Oregon, 2004-2006
Table 3. Treatment Admissions for Clackamas, Multnomah, and Washington Counties, by Drug, 2005-2006
Table 4. Methamphetamine Laboratory Seizures in Deschutes, Douglas, and Umatilla Counties, Oregon, 2004-2006
Table 5. Treatment Admissions for Deschutes, Douglas, and Umatilla Counties, by Drug, 2006

Preface

Figure 1. Oregon High Intensity Drug Trafficking Area and transportation infrastructure.

d-link

This assessment provides a strategic overview of the illicit drug situation in the Oregon High Intensity Drug Trafficking Area (HIDTA), highlighting significant trends and law enforcement concerns related to the trafficking and abuse of illicit drugs. The report was prepared through detailed analysis of recent law enforcement reporting, information obtained through interviews with law enforcement and public health officials, and available statistical data. The report is designed to provide policy makers, resource planners, and law enforcement officials with a focused discussion of key drug issues and developments facing the Oregon HIDTA region.

To Top     To Contents

Addresses

National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622

Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov

National Drug Intelligence Center
United States Department of Justice
Robert F. Kennedy Building (Room 1335)
950 Pennsylvania Avenue NW
Washington, DC 20530

Tel. (202) 432-4040
FAX (202) 514-4252

Web Addresses

ADNET:  http://ndicosa
DOJ:  http://www.usdoj.gov/ndic/
LEO:  https://cgate.leo.gov/http/leowcs.leopriv.gov/lesig/ndic/index.htm
RISS:  ndic.riss.net

To Top     To Contents     To Next Page

To Publications Page     To Home Page

UNCLASSIFIED